mada, CMSO & EVP, Takeda Pharmaceuticals & Former President of the Global Health Program, ‘The Bill & Melinda Gates Foundation Rising Stars Exhibit Access Health International AliveCor Arocell BioLamina Diabetes Tools Insulution MedUniverse Pilljogger Q-linea Concluding Luncheon Hosted by Magnus Tyrema

etes-related issues and CEO of Lyfebulb Dr. Karin Hehenberger, and the founder and former chairman of Human Genome Sciences and currently chairman of ACCESS Health International Dr. William A. Haseltine. Recommended by Forbes MOST POPULAR T TRENDING ON FACEBOOK The Inside Story of Marriott's High-Seas The 10

h centers, designed to care for 60,000 people per annum. In 2012, with HRSA's approval, we merged Tulane's program with a consortium of 10 FQHC's (Access Health) in southern Louisiana; a primary care base with about 250,000 patient encounters per annum. In 2010, Kathleen Sebelius (secretary of the Department